Mataveli Fabio D'Aguiar, Han Sang Won, Nader Helena Bonciani, Mendes Aline, Kanishiro Rose, Tucci Paulo, Lopes Antonio Carlos, Baptista-Silva Jose Carlos Costa, Marolla Ana Paula Cleto, de Carvalho Leonardo Pinto, Denapoli Priscila Martins Andrade, Pinhal Maria Aparecida da Silva
Department of Internal Medicine, Universidade Federal de Sao Paulo, Sao Paulo, SP, Brazil.
Growth Factors. 2009 Feb;27(1):22-31. doi: 10.1080/08977190802574765.
Cardiac remodeling is ultimately regulated by components of the extracellular matrix (ECM). We investigated the important role that growth factors play in the regulation of ECM remodeling that occurs as a consequence of myocardium damage.
Rats were submitted to the ligation of the left anterior coronary artery and pcDNA3-vascular endothelial growth factor (VEGF)(165) was immediately injected intramyocardially in the treated group. The animals were divided into large size myocardium infarction (LMI) and small size myocardium infarction, with or without gene transfer. The plasmid-containing DNA encoding VEGF(165) was injected into the cardiac muscle and its effect was observed on the ECM components. Glycosaminoglycans were identified and quantified by agarose gel based electrophoresis and ELISA as well as immunocytochemistry to examine specific cathepsin B, heparanase, and syndecan-4 changes. The amounts of hyaluronic acid (HA; p < 0.005), DS, chondroitin sulfate, and heparan sulfate (p < 0.001) were significantly increased in the LMI treated group in comparison to the other groups, which correlates with the decrease in the expression of heparanase. A decrease in the molecular mass of HA was found in the scar tissue of treated group.
The data obtained strongly support the idea that changes in the ECM and its components are important determinants of cardiac remodeling after myocardium infarct and may be essential for inflammatory response and attempt to stabilize the damage and provide a compensatory mechanisms to maintain cardiac output since the ECM components analyzed are involved with angiogenesis, cell proliferation and differentiation.
心脏重塑最终由细胞外基质(ECM)的成分调节。我们研究了生长因子在因心肌损伤而发生的ECM重塑调节中所起的重要作用。
将大鼠进行左冠状动脉结扎,治疗组立即心肌内注射pcDNA3-血管内皮生长因子(VEGF)(165)。动物被分为大面积心肌梗死(LMI)和小面积心肌梗死组,有或无基因转移。将编码VEGF(165)的含质粒DNA注射到心肌中,并观察其对ECM成分的影响。通过琼脂糖凝胶电泳、ELISA以及免疫细胞化学鉴定和定量糖胺聚糖,以检测组织蛋白酶B、乙酰肝素酶和多功能蛋白聚糖-4的特异性变化。与其他组相比,LMI治疗组的透明质酸(HA;p<0.005)、硫酸皮肤素(DS)、硫酸软骨素和硫酸乙酰肝素(p<0.001)含量显著增加,这与乙酰肝素酶表达的降低相关。在治疗组的瘢痕组织中发现HA的分子量降低。
获得的数据有力地支持了以下观点,即ECM及其成分的变化是心肌梗死后心脏重塑的重要决定因素,并且可能对于炎症反应以及稳定损伤并提供维持心输出量的代偿机制至关重要,因为所分析的ECM成分与血管生成、细胞增殖和分化有关。